On (b)(6) 2014 caller had a swollen knee and was diagnosed with a knee infection.
On (b)(6) 2014 her knee gave up on her and was told she had a torn acl, mcl and meniscus.
She had a 3 session therapy of orthovisc injection from (b)(6).
Right after the first injection she started to experience adverse reaction of knee pain, swelling, and flu like symptoms, fatigue, chills and headache.
She continues to experience pain and revisited her doctor in (b)(6) 2015 and was given a cortisone shot.
An mri was done on (b)(6) 2015 and was informed that she needs a debridement.
After the debridement another session of orthovisc injection was given from (b)(6) 2014 but these did not stop the pain.
She was then advised to get a knee replacement.
She contact a specialist for a second opinion and was given the care needed and the pain subsided with no further injections or surgery.
Through research on the web she learned about orthovisc injection and the adverse reaction on fda website which the first doctor failed to share with her.
Fda should take this device off the market.
|